May 5, 2014 08:00 UTC

Z-Medica Bolsters Hemostatic Product Line with Acquisition of Novacol®

WALLINGFORD, Conn.--(BUSINESS WIRE)-- Z-Medica, a leading developer and marketer of hemostatic agents, today announced that they have signed a definitive agreement with TAUREON, headquartered in The Netherlands, to acquire Novacol®, a Class III resorbable hemostatic product.

Novacol is currently sold in Europe and South Korea. Z-Medica will continue to support that marketing strategy while making plans to expand the product offering into other countries.

“Given our QuikClot portfolio of hemostatic dressings, it was a natural fit for us to augment both our product line and our international presence with Novacol,” said Z-Medica’s President and CEO Stephen J. Fanning. “Our current products are gauze-based and non-resorbable. Acquiring Novacol, which is a resorbable hemostat, is the first step towards expanding the Z-Medica portfolio and providing a wider range of innovative, safe, and effective products to the broader healthcare market.”

Used primarily in surgeries, Novacol is comprised of 100% high-quality, purified, natural long and short collagen fiber, which is resorbed by the body. The product is available as the soft, pliable Novacol® Pad, and Novacol® Fibrillar for use in cavities and irregular surfaces.

“Novacol is an effective product that will benefit from Z-Medica’s global distribution network,” said TAUREON CEO Dick van Kalkeren. “Z-Medica’s experience with QuikClot and their reputation as a leader in the hemostatic market ensures that Novacol will be able to compete favorably in the market. The transfer of Novacol also enables TAUREON to strengthen our focus in Europe on plastic and orthopedic surgery, human tissue and advanced wound care.”

About Z-Medica®

Z-Medica, LLC is a medical device company founded in 2002, developing fast acting, easy to use, hemostasis products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent for the Department of Defense and for use by all U.S. military forces as the first line hemostatic agent for traumatic bleeding. QuikClot products are developed and manufactured in the United States. Z-Medica, LLC is a privately-held company based in Wallingford, CT. For more information, visit www.z-medica.com.

About TAUREON

TAUREON has become a well-known and trusted company in the field of surgical specialties and advanced wound care products. You may be familiar with us because of our products such as HoneySoft® (both Skin Recovery Cream -SRC- and dressing) and SurfaSoft®. All these products have been developed by TAUREON and as IP-holder TAUREON is authorized to market them worldwide. However, TAUREON is also the holder of a vast portfolio of surgical license products in The Netherlands and/or other European countries, (like the Tutogen Biomaterials, BRAVA, the Avance nerve graft, etc.) and advanced wound care products (like Omiderm, Elasto-Gel, Hyiodine, HydroAid, etc.) and other quality products for which TAUREON owns the exclusive marketing rights in specific European regions.

Contacts

EVC Group
David Schemelia, 646-201-5431
dave@evcgroup.com


Source: Z-Medica, LLC